Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)

China flag China · Delayed Price · Currency is CNY
8.42
+0.37 (4.60%)
Jun 29, 2026, 3:04 PM CST
Market Cap3.21B -15.4%
Revenue (ttm)1.38B -16.4%
Net Income14.25M
EPS0.04
Shares Out 398.52M
PE Ratio218.02
Forward PEn/a
Dividend0.18 (2.24%)
Ex-Dividend DateJun 8, 2026
Volume11,622,628
Open8.03
Previous Close8.05
Day's Range7.86 - 8.56
52-Week Range7.88 - 14.55
Beta0.50
Analystsn/a
Price Targetn/a
Earnings DateAug 26, 2026

About SHE:301060

Shanghai Labway Clinical Laboratory Co., Ltd. engages in the sale of in-vitro diagnostic products in China. The company distributes in-vitro diagnostic instruments, reagents, and related accessories and consumables. It also provides third-party medical testing, pathological diagnosis services, precision medicine, CRO, and sample bank laboratory services; scientific research technology and testing; and professional technical support services. In addition, the company offers rental, business, and human resources services. Further, it operates Lan... [Read more]

Sector Healthcare
Founded 1993
Employees 1,245
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301060
Full Company Profile

Financial Performance

In 2025, SHE:301060's revenue was 1.45 billion, a decrease of -16.88% compared to the previous year's 1.74 billion. Losses were -30.75 million, -71.90% less than in 2024.

Financial Statements